Archives
-
3X (DYKDDDDK) Peptide: Evidence and Limits
2026-10-06
The 3X (DYKDDDDK) Peptide is a synthetic, triple-repeat FLAG epitope used conceptually for detection and affinity-based studies of recombinant proteins. Its product description supports sequence identity and intended applications, while the cited influenza study provides biological context but does not independently validate peptide performance.
-
VP39 Structure and Baculovirus Nucleocapsid Assembly
2026-10-05
A 2024 Nature Communications study uses a 3.2 Å cryo-EM helical reconstruction to show how baculovirus VP39 dimers form a 14-stranded nucleocapsid tube. The structure identifies a conserved VP39 fold, a zinc finger domain, and an intra-dimer sling that together clarify principles of baculovirus capsid assembly while leaving genome-packaging dynamics unresolved.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Overview
2026-10-05
MA3057 is an unconjugated rabbit monoclonal HMGB1 antibody described by APExBIO for research detection of human, mouse, and rat HMGB1. No matched paper evidence is available, so application performance and independent validation cannot be assessed.
-
HRP Anti-Rabbit IgG (H+L) Product Overview
2026-10-04
APExBIO lists SKU K1223 as an affinity-purified, HRP-conjugated goat anti-rabbit IgG secondary antibody for conceptual use in rabbit-antibody immunoassays. No matched paper evidence was provided, so independent performance claims cannot be assessed.
-
NHE1, Octanal, and Macrophage-Driven Atherosclerosis
2026-10-03
A 2025 Scientific Reports study identifies macrophage NHE1 as a downstream mediator connecting octanal/Olfr2 signaling with calcium-dependent ROS production, NLRP3 inflammasome activation, and atherosclerotic plaque progression. Its combined mouse and cell-model evidence supports NHE1 as a mechanistic link and possible therapeutic target, while the model-specific design leaves important questions about human relevance and pathway specificity.
-
Cy3 Goat Anti-Human IgG: Assay Insight
2026-10-02
The Cy3 Goat Anti-Human IgG (H+L) Antibody supports sensitive human IgG visualization across fluorescence, tissue, cytometric, and ELISA workflows. This article connects reagent selection with orthopoxvirus antibody research, emphasizing species matching, endpoint interpretation, and translational assay design.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-10-01
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, immunocytochemistry, immunohistochemistry, flow cytometry, and fluorescence microscopy workflows. It is a secondary reagent for rabbit IgG detection, not a direct-detection antibody, and its sodium azide-containing formulation requires validation before use in live-cell or other azide-sensitive assays.
-
γH2AX DNA Damage Detection Kit: 5 Lab Scenarios
2026-10-01
This scenario-based guide explains how the γH2AX DNA Damage Detection Kit (Mouse mAb/Red), SKU K2275, can complement viability, proliferation, apoptosis, and genotoxicity workflows. It covers assay design, two-color imaging, protocol standardization, interpretation, and practical product-selection criteria for DNA damage and repair research.
-
XPG Mutations, Ribosome Stress, and Cockayne Syndrome
2026-09-30
This study distinguishes a Cockayne syndrome phenotype from an XP-only phenotype caused by mutations in the same XPG gene. Its central contribution is linking the Cockayne syndrome cellular state to defective RNA polymerase I activity, impaired rRNA maturation, eIF2α phosphorylation, and a shift toward IRES-dependent translation, thereby implicating ribosomal stress and translational control in disease pathogenesis.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-30
HRP Goat Anti-Rabbit IgG (H+L) Antibody provides an HRP-labeled secondary reagent for detecting rabbit IgG primary antibodies in Western blot, ELISA, IHC, and ICC workflows. It should be used with rabbit primaries and assay-appropriate controls, not as a universal secondary antibody, diagnostic reagent, or substitute for primary-antibody validation.
-
ELISA Stop Solution in Quantitative Immunoassays
2026-09-29
Learn how ELISA Stop Solution controls endpoint chemistry, improves plate-to-plate consistency, and supports interpretation of vaccine immunogenicity data. This guide connects assay design with findings from a bivalent H5/H7 mRNA–LNP vaccine study.
-
3X (DYKDDDDK) Peptide: Workflow Guide
2026-09-29
Use the 3X FLAG peptide to improve competitive elution, confirm FLAG fusion proteins, and control metal-sensitive immunoassays. This practical guide connects recombinant protein workflows with structural insights from human PSS2 research, while emphasizing assay controls and troubleshooting.
-
ASB3 Targets MAVS to Suppress Antiviral Immunity
2026-09-28
The 2024 Cell Death & Differentiation study identifies ASB3 as an E3 ubiquitin ligase that suppresses antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS at K297. Its genetic, biochemical, infection, and animal-model evidence positions ASB3 as a negative regulator of RIG-I-like receptor signaling and provides a framework for experimentally validating MAVS-centered antiviral mechanisms.
-
NETosis and IL-36R Feedback in Psoriasis
2026-09-28
The study links TLR3- and P2X7R-associated signals to neutrophil extracellular trap formation and identifies IL-36R signaling as an amplifier of inflammatory responses in psoriasis models. Its findings support further investigation of the NET–IL-36R relationship while highlighting the importance of disease timing and model-specific validation.
-
Homoharringtonine Against SARS-CoV-2: Evidence and Limits
2026-09-27
A 2025 study reports that homoharringtonine suppressed replication of four tested coronaviruses and was associated with rapid upper-respiratory SARS-CoV-2 clearance in mouse and small human cohorts. The findings support further investigation of this protein-elongation inhibitor as a locally delivered antiviral candidate, but do not establish clinical efficacy, safety, or first-line use.